Today is Human Genome Day at the US Supreme Court ~pj Updated 4Xs - transcript

Today is human genome day at the US Supreme Court. There will be oral argument on Association for Molecular Pathology v. Myriad Genetics, Inc.. The link will take you to the ABA's collection of amicus briefs, and there are many of them, and the merits briefs. The question before the court is this:

QUESTION PRESENTED: Many patients seek genetic testing to see if they have mutations in their genes that are associated with a significantly increased risk of breast or ovarian cancer. Respondent Myriad Genetics obtained patents on two human genes that correlate to this risk, known as BRCA1 and BRCA2. These patents claim every naturally-occurring version of those genes, including mutations, on the theory that Myriad invented something patent--eligible simply by removing ("isolating") the genes from the body. Petitioners are primarily medical professionals who regularly use routine, conventional genetic testing methods to examine genes, but are prohibited from examining the human genes that Myriad claims to own. This case therefore presents the following questions:

1. Are human genes patentable?

2. Did the court of appeals err in upholding a method claim by Myriad that is irreconcilable with this Court's ruling in Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S. Ct. 1289 (2012)?

3. Did the court of appeals err in adopting a new and inflexible rule, contrary to normal standing rules and this Court's decision in MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007), that petitioners who have been indisputably deterred by Myriad's "active enforcement" of its patent rights nonetheless lack standing to challenge those patents absent evidence that they have been personally threatened with an infringement action?

Can you believe that is the question, are human genes patentable? But it is what the court has to decide. How in the world did we get to such a place? The argument [PDF] by Myriad is that they aren't patenting genes *in* the body, only after they've removed them and done things to them that are not done in the body, arguing that "isolated" DNA can perform functions that DNA can't. But ACLU's lawyer points out in its reply brief, you can't patent gold after you take it out of a stream just because you can make jewelry with it or patent kidneys after you remove them from one body and transplant them:

Myriad is in effect arguing that it may obtain a patent on a product or law of nature itself if it finds a new use for it. Under this theory, Section 101 would not prohibit someone from obtaining a patent on gold if she found a new use for gold. As a matter of law, that argument is incorrect.

So that is what is at stake.